Chronic Kidney Disease News

The FDA has granted orphan drug designation for felzartamab, an antibody-mediated rejection therapy for kidney transplant recipients, according to a press release.

Patients with rare kidney diseases have greater 5-year rates of kidney failure but higher survival than those with chronic kidney disease stages 3 through 5, according to published data.

Niacinamide may be an effective method to reduce serum phosphate concentrations in patients with kidney failure on hemodialysis, according to results of a published crossover trial.

The American Society of Nephrology and Home Dialysis University are offering scholarships to improve home therapies education for nephrology fellows, according to a press release.

Peritoneal equilibration test scores may be associated with dialysate-to-plasma folate concentration levels in adults on peritoneal dialysis, according to a published study.

Patients with chronic kidney disease may have difficulty accessing equitable treatment even in a country with universal health care, according to published findings.

A computerized clinical decision support system could improve the management of uncontrolled hypertension in adults with chronic kidney disease, according to published data.

GLP-1 receptor agonists come with known adverse events — some common and some rare — but recent reports by the public of alopecia and suicidal ideation have the FDA investigating.

Home hemodialysis may be associated with a higher rate of pregnancy than peritoneal dialysis in women with kidney failure, according to recently published data. Younger and Black women are liker to become pregnant among this population.

Kidney Disease: Improving Global Outcomes has announced the release of its 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.